Search Result

Results for "

Inhaled

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5-HT Receptor (1) ADC Cytotoxin (3) Adrenergic Receptor (13) Anaplastic lymphoma kinase (ALK) (1) Apoptosis (1) Autophagy (1) Bacterial (3) Biochemical Assay Reagents (2) c-Fms (1) c-Kit (1) Chloride Channel (2) Cytochrome P450 (1) DNA/RNA Synthesis (1) Drug Metabolite (2) Endogenous Metabolite (1) Endonuclease (1) Fluorescent Dye (1) Glucocorticoid Receptor (11) Influenza Virus (3) Isotope-Labeled Compounds (4) JAK (2) Lipoxygenase (1) mAChR (9) p38 MAPK (3) PDGFR (1) Phosphodiesterase (PDE) (4) PI3K (2) RSV (1) Smo (2) Src (1) STAT (1)
By Research Areas:	Cancer (8) Cardiovascular Disease (5) Endocrinology (9) Infection (10) Inflammation/Immunology (36) Metabolic Disease (2) Neurological Disease (6)

By Targets:

5-HT Receptor (1)

ADC Cytotoxin (3)

Adrenergic Receptor (13)

Anaplastic lymphoma kinase (ALK) (1)

Apoptosis (1)

Autophagy (1)

Bacterial (3)

Biochemical Assay Reagents (2)

c-Fms (1)

c-Kit (1)

Chloride Channel (2)

Cytochrome P450 (1)

DNA/RNA Synthesis (1)

Drug Metabolite (2)

Endogenous Metabolite (1)

Endonuclease (1)

Fluorescent Dye (1)

Glucocorticoid Receptor (11)

Influenza Virus (3)

Isotope-Labeled Compounds (4)

JAK (2)

Lipoxygenase (1)

mAChR (9)

p38 MAPK (3)

PDGFR (1)

Phosphodiesterase (PDE) (4)

PI3K (2)

RSV (1)

Smo (2)

Src (1)

STAT (1)

By Research Areas:

Cancer (8)

Cardiovascular Disease (5)

Endocrinology (9)

Infection (10)

Inflammation/Immunology (36)

Metabolic Disease (2)

Neurological Disease (6)

Inhibitors & Agonists

Biochemical Assay Reagents

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B0629

Mometasone	Glucocorticoid Receptor	Metabolic Disease Cancer
Mometasone is an inhaled glucocorticoid. Mometasone can be used in mild asthma with a low sputum eosinophil level. Mometasone has the potential for the research of chronic hand eczema and rhinosinusitis .

HY-W040269

Dehydrothio-p-toluidine 1 Publications Verification DHPT	Fluorescent Dye	Others
Dehydrothio-p-toluidine (DHPT) is a chemical intermediate used in dyestuff production. Dehydrothio-p-toluidine shows inhalation toxicity in acute and subchronic conditions .

HY-100087

Budesonide impurity C	Glucocorticoid Receptor	Inflammation/Immunology Cancer
Budesonide impurity C is an impurity of Budesonide. Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist .

HY-119708

Ensifentrine 1 Publications Verification RPL-554	Phosphodiesterase (PDE)	Inflammation/Immunology
Ensifentrine (RPL-554) is an inhaled first-in-class dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 with IC₅₀s of 0.4 nM and 1479 nM, respectively. Ensifentrine has bronchoprotective and anti-inflammatory activities. Ensifentrine can be used for chronic obstructive pulmonary disease (COPD) research .

HY-13580

Budesonide 4 Publications Verification	Glucocorticoid Receptor ADC Cytotoxin	Inflammation/Immunology Cancer
Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist. Budesonide decreases the size of lung tumors, reverses DNA hypomethylation and modulates mRNA expression of genes. Budesonide is an anti-inflammatory agent used for asthma .

HY-B0603

Fluticasone	Smo Glucocorticoid Receptor	Infection Inflammation/Immunology Endocrinology
Fluticasone is an inhaled corticosteroid used for respiratory research. Fluticasone is a Smo agonist with an IC₅₀ value of 99 nM. Fluticasone activates Hedgehog signaling and promotes the proliferation of primary neuronal stem or precursor cells .

HY-132849

Nezulcitinib TD-0903	JAK	Infection Inflammation/Immunology
Nezulcitinib (TD-0903) is an inhaled and lung-selective pan-Janus kinase (JAK) inhibitor. Nezulcitinib can be used for the research of COVID-19 associated acute lung injury and impaired oxygenation .

HY-B0629R

Mometasone (Standard)	Glucocorticoid Receptor	Metabolic Disease
Mometasone (Standard) is the analytical standard of Mometasone. This product is intended for research and analytical applications. Mometasone is an inhaled glucocorticoid. Mometasone can be used in mild asthma with a low sputum eosinophil level. Mometasone has the potential for the research of chronic hand eczema and rhinosinusitis .

HY-18862

PF-03715455	p38 MAPK	Inflammation/Immunology
PF-03715455 is a potent inhaled p38 MAPK inhibitor. PF-03715455 shows some selectivity for p38α over p38β with respective IC₅₀ values of 0.88 and 23 nM. PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC₅₀=1.7 nM). PF-03715455 has potential for the treatment of COPD (chronic obstructive pulmonary disease) .

HY-B0603R

Fluticasone (Standard)	Smo Glucocorticoid Receptor	Infection Inflammation/Immunology Endocrinology
Fluticasone (Standard) is the analytical standard of Fluticasone. This product is intended for research and analytical applications. Fluticasone is an inhaled corticosteroid used for respiratory research. Fluticasone is a Smo agonist with an IC50 value of 99 nM. Fluticasone activates Hedgehog signaling and promotes the proliferation of primary neuronal stem or precursor cells .

HY-120802

Navafenterol AZD-8871; LAS191351	mAChR Adrenergic Receptor	Inflammation/Immunology
Navafenterol (AZD-8871) is an inhaled dual-acting, potent, selective, and long-lasting M3-antagonist/β2-agonist (MABA) with long-lasting effects and favorable safety profile. The pIC₅₀ is 9.5 for human M3 receptor, and the pEC₅₀ is 9.5 for β2-adrenoceptor. Navafenterol can be used for the research of chronic obstructive pulmonary disease (COPD). Bronchoprotective and antisialagogue effects. Favorable cardiovascular profile .

HY-120802A

Navafenterol saccharinate AZD-8871 saccharinate; LAS191351 saccharinate	mAChR Adrenergic Receptor	Infection Inflammation/Immunology
Navafenterol (AZD-8871) saccharinate is an inhaled dual-acting, potent, selective, and long-lasting M3-antagonist/β2-agonist (MABA) with long-lasting effects and favorable safety profile. The pIC₅₀ is 9.5 for human M3 receptor, and the pEC₅₀ is 9.5 for β2-adrenoceptor. Navafenterol saccharinate can be used for the research of chronic obstructive pulmonary disease (COPD). Bronchoprotective and antisialagogue effects. Favorable cardiovascular profile .

HY-103672

AZD7624	p38 MAPK Autophagy	Inflammation/Immunology
AZD7624 is an inhaled p38 inhibitor, with potent anti-inflammatory activity.

HY-W039897

Methyl α-D-mannopyranoside 1 Publications Verification α-Methyl-D-mannoside	Bacterial	Inflammation/Immunology
Methyl α-D-mannopyranoside could target macrophages in anti-tuberculosis inhalation therapy .

HY-159952

ALK5-IN-84	Anaplastic lymphoma kinase (ALK)	Cardiovascular Disease Neurological Disease Inflammation/Immunology Cancer
ALK5-IN-84 (Compound 23) is an ALK5 inhibitor with a pK_i value of 9.35 against hALK5. When administered via inhalation, ALK5-IN-84 exhibits significant ALK5 inhibitory activity. ALK5-IN-84 is promising for the development of inhaled ALK5 inhibitors .

HY-W015593

Methylhexanamine hydrochloride	Adrenergic Receptor	Cardiovascular Disease
Methylhexanamine hydrochloride is an aliphatic amine and a vasoconstrictor that can be administered by inhalation to the nasal mucosa to exert its effect as a nasal decongestant .

HY-122317

Menthol glucuronide	Drug Metabolite	Others
Menthol glucuronide, a metabolite of Menthol (HY-N1369), is a plasma and urine biomarker of acute Menthol inhalation .

HY-115870

AZD8154	PI3K	Inflammation/Immunology
AZD8154 is a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.

HY-B1481B

Isoetharine hydrochloride Isoetarine hydrochloride	Adrenergic Receptor	Infection
Isoetharine hydrochloride is selective, short-acting and orally active β-agonist which is widely used as a bronchodilator in the research of inhalation research .

HY-W181626A

Tiprenolol hydrochloride DU 21445 hydrochloride	5-HT Receptor	Cardiovascular Disease
Tiprenolol hydrochloride is a β-adrenoceptor blocker. Tiprenolol hydrochloride abolished ventricular arrhythmias induced by intravenous epinephrine in dogs receiving halothane inhalation .

HY-14786

Darotropium bromide GSK233705	mAChR	Neurological Disease Inflammation/Immunology
Darotropium bromide (GSK233705), a long-acting muscarinic antagonist and an inhaled anticholinergic, can be used for the research of chronic obstructive pulmonary disease (COPD) .

HY-157568S

Budesonide acid-d8	Isotope-Labeled Compounds	Others
Budesonide acid-d8 is a deuterium labeled Budesonide acid. Budesonide acid is an impurity of Budesonide. Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist .

HY-N2085

L-Perillaldehyde (S)-(-)-Perillaldehyde; (S)-Perillaldehyde	Others	Neurological Disease
L-Perillaldehyde is a major component in the essential oil containing in Perillae Herba. Inhalation of L-Perillaldehyde shows antidepressant-like activity through the olfactory nervous function .

HY-117024

Abediterol napadisylate AZD0548 napadisylate; LAS100977 napadisylate	Adrenergic Receptor	Inflammation/Immunology
Abediterol napadisylate is an inhaled long-acting β2-adrenoceptor agonist (LABA) and can be used for the research of asthma and chronic obstructive pulmonary disease (COPD) .

HY-A0225B

Pirbuterol dihydrochloride (±)-Pirbuterol(dihydrochloride); ARA 211(dihydrochloride)	Endogenous Metabolite	Cardiovascular Disease
Pirbuterol ((±)-Pirbuterol) dihydrochloride is a beta 2 adrenergic agonist with bronchodilator activity. Pirbuterol dihydrochloride is comparable in duration of action to albuterol when administered by inhalation. Pirbuterol dihydrochloride demonstrates similar beta 2 selectivity to albuterol in humans.

HY-108243

AZD5423 2 Publications Verification	Glucocorticoid Receptor	Inflammation/Immunology Endocrinology
AZD5423 is an inhaled, potent, selective, and non-steroidal glucocorticoid receptor (GR) modulator (SGRM) . AZD5423 effectively reduces allergen-induced responses in subjects with mild allergic asthma .

HY-115871

PDE4-IN-4	Phosphodiesterase (PDE) mAChR	Others
PDE4-IN-4 is a dual M3 (pIC₅₀ = 10.2) antagonist-PDE4 (pIC₅₀ = 8.8) inhibitor for the inhaled research of pulmonary diseases.

HY-111144

Abediterol AZD0548; LAS100977	Adrenergic Receptor	Inflammation/Immunology
Abediterol (LAS100977) is an inhaled long-acting β2-adrenoceptor agonist (LABA) and can be used for the research of asthma and chronic obstructive pulmonary disease (COPD) .

HY-14296

PF-610355	Adrenergic Receptor	Inflammation/Immunology
PF-610355 is a long-acting inhaled β₂-adrenoreceptor agonist, with an EC₅₀ of 0.26 nM. PF-610355 has the potential for the study of asthma and COPD .

HY-14144

Aclidinium Bromide 5 Publications Verification LAS 34273; LAS-W 330	mAChR	Inflammation/Immunology
Aclidinium Bromide (LAS 34273; LAS-W 330) is a long-acting, inhaled muscarinic antagonist. Aclidinium Bromide has the potential for chronic obstructive pulmonary disease (COPD) research .

HY-A0234

Stepronin Prostenoglycine; TTPG; Tiase	Chloride Channel	Endocrinology
Stepronin (Prostenoglycine) is an orally active expectorant (inhalation administration is preferable to oral administration). Stepronin inhibits airway secretion in vitro by reducing Cl ^- secretion from epithelial cells and mucus glycoprotein secretion from submucosal glands .

HY-102038

PC786	RSV	Infection
PC786 is an inhaled respiratory syncytial virus (RSV) L protein polymerase inhibitor. PC786 demonstrates potent antiviral activity against RSV-A (IC₅₀ <0.09 to 0.71 nM) and RSV-B (IC₅₀, 1.3 to 50.6 nM) .

HY-W039897R

Methyl α-D-mannopyranoside (Standard) α-Methyl-D-mannoside (Standard)	Bacterial	Inflammation/Immunology
Methyl α-D-mannopyranoside (Standard) is the analytical standard of Methyl α-D-mannopyranoside. This product is intended for research and analytical applications. Methyl α-D-mannopyranoside could target macrophages in anti-tuberculosis inhalation therapy[1].

HY-109190

Seralutinib 1 Publications Verification GB002; PK10571	PDGFR c-Fms c-Kit	Cardiovascular Disease
Seralutinib (GB002) is an inhaled PDGFRα and PDGFRβ inhibitor. Seralutinib also targets to CSF1R and c-KIT with IC₅₀s of 8 nM and 14 nM, respectively. Seralutinib (GB002) is used in the study for pulmonary arterial hypertension .

HY-N2085R

L-Perillaldehyde (Standard)	Others	Neurological Disease
L-Perillaldehyde (Standard) is the analytical standard of L-Perillaldehyde. This product is intended for research and analytical applications. L-Perillaldehyde is a major component in the essential oil containing in Perillae Herba. Inhalation of L-Perillaldehyde shows antidepressant-like activity through the olfactory nervous function .

HY-14818C

Laninamivir octanoate hydrate CS-8958 hydrate	Influenza Virus	Infection
Laninamivir octanoate hydrate (CS-8958 hydrate), a prodrug of Laninamivir, is a long-acting neuraminidase (NA) inhibitor with anti-influenza virus activity. Laninamivir octanoate hydrate shows anti-influenza activity against Oseltamivir-resistant viruses, and also against the pandemic influenza viruses .

HY-14818A

Laninamivir octanoate CS-8958	Influenza Virus	Infection
Laninamivir octanoate (CS-8958), a proagent of Laninamivir, is a long-acting neuraminidase (NA) inhibitor with anti-influenza virus activity. Laninamivir octanoate shows anti-influenza activity against Oseltamivir-resistant viruses, and also against the pandemic influenza viruses .

HY-14818B

Laninamivir TFA R 125489 TFA	Influenza Virus	Infection
Laninamivir TFA (R 125489 TFA) is an antiviral compound with inhibitory and prophylactic activity against influenza A and B viruses. Laninamivir TFA is a long-acting neuraminidase inhibitor administered by nasal inhalation. Laninamivir TFA has shown good safety and efficacy in the inhibition of influenza viruses .

HY-76025S

1,4-Dibromobenzene-d4 p-Dibromobenzene-d₄	Isotope-Labeled Compounds	Inflammation/Immunology
1,4-Dibromobenzene-d₄ is a deuterium labeled 1,4-Dibromobenzene. 1,4-Dibromobenzene is used as a fumigant and as a chemical intermediate for pharmaceuticals. Inhalation exposure gives rise to dizziness and chokingwhereas contact with skin or eye produces inflammation and burning in humans .

HY-W778340

16α-Hydroxy-11-keto prednisolone	Drug Metabolite Glucocorticoid Receptor	Inflammation/Immunology Cancer
16α-Hydroxy-11-keto prednisolone (compound M-X) is a metabolite of Budesonide (HY-13580). Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist. Budesonide is a widely used for study of asthma, rhinitis, and inflammatory bowel disease .

HY-13580S

Budesonide-d8	Glucocorticoid Receptor	Inflammation/Immunology Cancer
Budesonide-d₈ is the deuterium labeled Budesonide. Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist. Budesonide decreases the size of lung tumors, reverses DNA hypomethylation and modulates mRNA expression of genes. Budesonide is an anti-inflammatory agent used for asthma .

HY-W742981

Budesonide-d6	Isotope-Labeled Compounds Glucocorticoid Receptor ADC Cytotoxin	Inflammation/Immunology Cancer
Budesonide-d₆ is deuterium labeled Budesonide. Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist. Budesonide decreases the size of lung tumors, reverses DNA hypomethylation and modulates mRNA expression of genes. Budesonide is an anti-inflammatory agent used for asthma .

HY-A0234R

Stepronin (Standard)	Chloride Channel	Endocrinology
Stepronin (Standard) is the analytical standard of Stepronin. This product is intended for research and analytical applications. Stepronin (Prostenoglycine) is an orally active expectorant (inhalation administration is preferable to oral administration). Stepronin inhibits airway secretion in vitro by reducing Cl ^- secretion from epithelial cells and mucus glycoprotein secretion from submucosal glands .

HY-14144R

Aclidinium (Bromide) (Standard)	mAChR	Inflammation/Immunology
Aclidinium (Bromide) (Standard) is the analytical standard of Aclidinium (Bromide). This product is intended for research and analytical applications. Aclidinium Bromide (LAS 34273; LAS-W 330) is a long-acting, inhaled muscarinic antagonist. Aclidinium Bromide has the potential for chronic obstructive pulmonary disease (COPD) research .

HY-14301

Olodaterol 1 Publications Verification BI1744	Adrenergic Receptor	Inflammation/Immunology Endocrinology
Olodaterol (BI1744) is a selective, long acting β₂-adrenoceptor (β₂-AR) agonist (EC₅₀=0.1 nM and pK_i= 9.14 for human β₂-adrenoceptor, respectively). Olodaterol can be used for chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis .

HY-14301AR

Olodaterol (hydrochloride) (Standard)	Adrenergic Receptor	Inflammation/Immunology Endocrinology
Olodaterol (hydrochloride) (Standard) is the analytical standard of Olodaterol (hydrochloride). This product is intended for research and analytical applications. Olodaterol (BI1744) hydrochloride is a selective, long acting β₂-adrenoceptor (β₂-AR) agonist (EC₅₀=0.1 nM and pK_i= 9.14 for human β₂-adrenoceptor, respectively). Olodaterol can be used for chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis .

HY-14301A

Olodaterol hydrochloride 1 Publications Verification BI1744 hydrochloride	Adrenergic Receptor	Inflammation/Immunology Endocrinology
Olodaterol (BI1744) hydrochloride is a selective, long acting β₂-adrenoceptor (β₂-AR) agonist (EC₅₀=0.1 nM and pK_i= 9.14 for human β₂-adrenoceptor, respectively). Olodaterol can be used for chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis .

HY-13580R

Budesonide (Standard) 4 Publications Verification	Glucocorticoid Receptor ADC Cytotoxin	Inflammation/Immunology Cancer
Budesonide (Standard) is the analytical standard of Budesonide. This product is intended for research and analytical applications. Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist. Budesonide decreases the size of lung tumors, reverses DNA hypomethylation and modulates mRNA expression of genes. Budesonide is an anti-inflammatory agent used for asthma .

HY-115871A

(Rac)-PDE4-IN-4	mAChR Phosphodiesterase (PDE)	Others
(Rac)-PDE4-IN-4 is the diastereomer mixture of PDE4-IN-4 (HY-115871). PDE4-IN-4 is a dual M3 (pIC₅₀ = 10.2) antagonist-PDE4 (pIC₅₀ = 8.8) inhibitor for the inhaled research of pulmonary diseases .

HY-12980A

Batefenterol Succinate GSK961081 Succinate; TD-5959 Succinate	Adrenergic Receptor mAChR	Neurological Disease
Batefenterol Succinate (GSK961081 Succinate) is a first-of-its-kind inhaled bifunctional bronchodilator with smooth muscle relaxant properties. The activities of Batefenterol Succinate include acting as a smooth muscle parasympathetic antagonist and a beta2-adrenoceptor agonist. Batefenterol Succinate is used to improve respiratory function, especially in patients with chronic obstructive pulmonary disease (COPD) .

Cat. No.	Product Name	Type

HY-W251428

Phosphatidylglycerols (egg) sodium salt

Egg PG

Drug Delivery

Phosphatidylglycerols (PG) is a selective inhibitor targeting the TLR4 accessory protein CD14/MD-2 complex, inhibiting LPS or virus (such as RSV)-mediated inflammatory signaling pathways through competitive binding. Phosphatidylglycerols directly bind to viral particles to block infection, inhibit COX-2 expression to reduce the release of inflammatory factors (IL-6, IL-8), and improve oxidative stress by regulating mitochondrial membrane phospholipid remodeling. Phosphatidylglycerols can be taken orally or by inhalation and can be used in the study of chronic inflammatory diseases (such as atherosclerosis) and respiratory viral infections (such as RSV) .

HY-112624J

Dextran T4 (MW 4,000)

Dextran 4; Dextran D4; Dextran T4(MW 3200-4800)

Thickeners

Dextran 4,000 is a mucus rheology modifier. The dextran molecules in Dextran 4,000 can reduce the cross-link density of mucus through osmotic effects and hydrogen bond substitution, and reduce viscoelasticity and improve the mucociliary/cough clearance index by destroying the DNA-mucin network structure in mucus. Dextran 4,000 has the ability to improve the rheological properties and clearance ability of cystic fibrosis (CF) sputum, and can be used in the study of inhalation therapy or aerosol delivery of mucostatic respiratory diseases. The Dextran series of compounds are also natural polysaccharide drug carriers that can be connected to drugs through covalent bonding methods such as ester bonds, amide bonds or click chemistry, or self-assembled to form carriers such as nanoparticles and hydrogels. Dextran is biodegradable and biocompatible, and can achieve targeted delivery and controlled release of drugs. Dextran derivatives can prolong the half-life of drugs, increase local concentrations, and reduce the activity of immune clearance .

HY-W250172

Polyethylene glycol tert-octylphenyl ether X-405

Surfactants

Polyethylene?glycol?tert-octylphenyl?ether X-405 is a nonionic surfactant commonly used in a variety of industrial and research applications. Polyethylene?glycol?tert-octylphenyl?ether X-405 belongs to the family of polyethylene glycol (PEG) ethers with a hydrophilic head and lipophilic tail and is suitable for use in emulsions, detergents and solubilizers. Polyethylene?glycol?tert-octylphenyl?ether X-405 is particularly useful in the study of membrane proteins, where it is used to solubilize and stabilize proteins for structural analysis techniques. It is also used in a variety of other applications, including drug delivery systems, nanotechnology, and diagnostic analysis. Additionally, Polyethylene?glycol?tert-octylphenyl?ether X-405 is used in the production of microemulsions, salves and lotions due to its emulsifying and solubilizing properties. However, it can be toxic if ingested or inhaled, so proper handling and safety precautions are required.

Cat. No.	Product Name	Category	Target	Chemical Structure